Novartis Investigative Site

Clamart 92141

1 studies enrolling now · 5 studies all time

What they study most

Healthy Volunteers, Pulmonary Arterial Hypertension, Heart Failure With Reduced Ejection Fraction (HF-rEF), Non-Small Cell Lung Cancer, Pulmonary Arterial Hypertension

Studies at this site

• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) — Recruiting now
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Imatinib (QTI571) in Pulmonary Arterial Hypertension — Completed
• Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) — Stopped early